Verition Fund Management
OLMA icon

Verition Fund Management’s Olema Pharmaceuticals OLMA Stock Holding History

Verition Fund Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,382
Closed -$835K – 3177
2025
Q4 		$835K Buy
+33,382
New +$594K ﹤0.01% 2295
2025
Q2 		– Sell
-25,125
Closed -$94.5K – 3790
2025
Q1 		$94.5K Sell
25,125
-4,515
-15% -$22.7K ﹤0.01% 3159
2024
Q4 		$173K Buy
+29,640
New +$296K ﹤0.01% 3010
2024
Q3 		– Sell
-18,539
Closed -$201K – 3432
2024
Q2 		$201K Sell
18,539
-103,639
-85% -$1.12M ﹤0.01% 2599
2024
Q1 		$1.38M Buy
+122,178
New +$1.58M 0.01% 1439

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Verition Fund Management's OLMA Position: Q1 2026 in Review

Verition Fund Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 33,382 shares — an estimated $835K sold.

Verition Fund Management first reported a position in OLMA in Q1 2024 and held it in 5 quarters. The position peaked at $1.38M in Q1 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Verition Fund Management reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 33,382 Olema Pharmaceuticals shares in Q1 2026, an estimated $835K.
  • Verition Fund Management first reported a position in Olema Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Verition Fund Management's Olema Pharmaceuticals position peaked at $1.38M in Q1 2024.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.